Bayesian Capital Management’s Northrop Grumman NOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-1,800
Closed -$845K 854
2024
Q4
$845K Buy
+1,800
New +$905K 0.1% 267
2021
Q2
Sell
-900
Closed -$291K 571
2021
Q1
$291K Buy
+900
New +$271K 0.07% 357
2019
Q2
Sell
-1,185
Closed -$319K 634
2019
Q1
$319K Buy
+1,185
New +$323K 0.06% 376
2018
Q2
Sell
-1,400
Closed -$489K 674
2018
Q1
$489K Sell
1,400
-6,126
-81% -$2.05M 0.12% 275
2017
Q4
$2.31M Buy
+7,526
New +$2.26M 0.47% 36
2017
Q1
Sell
-9,831
Closed -$2.29M 614
2016
Q4
$2.29M Buy
+9,831
New +$2.29M 0.57% 10
2016
Q1
Sell
-3,600
Closed -$680K 414
2015
Q4
$680K Buy
+3,600
New +$660K 0.97% 6

Other funds holding NOC

Bayesian Capital Management's NOC Position: Q1 2025 in Review

Bayesian Capital Management sold out of Northrop Grumman (NOC) in Q1 2025, closing a stake of 1,800 shares — an estimated $845K sold.

Bayesian Capital Management first reported a position in NOC in Q4 2015 and held it in 7 quarters. The position peaked at $2.31M in Q4 2017. 1,669 funds tracked by Wall St. Rank hold NOC as of Q1 2025.

  • Bayesian Capital Management reported no remaining Northrop Grumman position as of Q1 2025 after selling out during the quarter.
  • Bayesian Capital Management sold 1,800 Northrop Grumman shares in Q1 2025, an estimated $845K.
  • Bayesian Capital Management first reported a position in Northrop Grumman in Q4 2015 and held it in 7 quarters.
  • Bayesian Capital Management's Northrop Grumman position peaked at $2.31M in Q4 2017.
  • 1,669 funds tracked by Wall St. Rank held Northrop Grumman as of Q1 2025.

Based on Bayesian Capital Management's 13F filing for Q1 2025, filed 15 May 2025.